Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential Changes of Serum KL-6 Predict Progression in Interstitial Lung Disease

NCT02960672 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT02960672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02960672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential Changes of Serum KL-6 Predict Progression in Interstitial Lung Disease
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2013
Completion date
December 31, 2018
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, desquamative